Instituto de Investigación e Innovación en Ciencias Biomédicas (INiBICA)
Instituto de investigación
Ignacio
Martín-Loeches
Publicaciones en las que colabora con Ignacio Martín-Loeches (28)
2024
-
Association of obesity on the outcome of critically ill patients affected by COVID-19
Medicina Intensiva, Vol. 48, Núm. 3, pp. 142-154
2023
-
A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients
Medicina Intensiva, Vol. 47, Núm. 1, pp. 23-33
-
Correction: Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study (Annals of Clinical Microbiology and Antimicrobials, (2023), 22, 1, (90), 10.1186/s12941-023-00626-7)
Annals of Clinical Microbiology and Antimicrobials
-
Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study
Scientific reports, Vol. 13, Núm. 1, pp. 6553
2022
-
Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19
Journal of Critical Care, Vol. 69
-
Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients
Journal of Infection, Vol. 85, Núm. 4, pp. 374-381
-
Prior influenza vaccine is not a risk factor for bacterial coinfection in patients admitted to the ICU due to severe influenza
Medicina Intensiva, Vol. 46, Núm. 8, pp. 436-445
-
Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units
Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89
2021
-
Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study
Annals of Intensive Care, Vol. 11, Núm. 1
-
Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain
Critical Care, Vol. 25, Núm. 1
-
Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU
Medicina Intensiva, Vol. 45, Núm. 8, pp. 485-500
-
Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study
The Lancet Regional Health - Europe, Vol. 11
-
Prognostic value of procalcitonin and c-reactive protein in 1608 critically ill patients with severe influenza pneumonia
Antibiotics, Vol. 10, Núm. 4
2020
-
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study
Intensive Care Medicine, Vol. 46, Núm. 7, pp. 1404-1417
-
The clinical relevance of oliguria in the critically ill patient: Analysis of a large observational database
Critical Care, Vol. 24, Núm. 1
2019
-
The association of cardiovascular failure with treatment for ventilator-associated lower respiratory tract infection
Intensive Care Medicine, Vol. 45, Núm. 12, pp. 1753-1762
2018
-
Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)
Intensive Care Medicine, Vol. 44, Núm. 3, pp. 337-344
-
Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study
Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482
2017
-
Decision-Making on Withholding or Withdrawing Life Support in the ICU: A Worldwide Perspective
Chest, Vol. 152, Núm. 2, pp. 321-329
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1